C12N 2502/07
Endocrine cells
Official title: endocrine cells
C12N2502/07 (Endocrine cells) appears on 6 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 8
- Assignees
- 5
- Inventors
- 22
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 2 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Subgroups
Granted patents
Recent patents
- Differentiation induction from human pluripotent stem cells into hypothalamic neurons5 Aug 2025US 12,378,518 B2National University Corporation Nagoya University
- Trabecular meshwork stem cells26 Jun 2018US 10,004,766 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Conditioned medium and proliferated cell lines produced therefrom25 Dec 2012US 8,337,829 B2University of Chile
- Proliferated cell lines and uses thereof20 Mar 2012US 8,137,662 B2University of Chile
- Proliferated cell lines and uses thereof26 Aug 2008US 7,416,885 B2University of Chile
- Creation of Inducible Pluripotent Stem Cell Derived T Regulatory Cells by In Vitro Recapitulation ofThymic Development23 Jan 2025US 2025/0027044 A1Creative Medical Technologies, Inc.
- Differentiation induction from human pluripotent stem cells into hypothalamic neurons10 Jan 2019US 2019/0010452 A1National University Corporation Nagoya University
- Trabecular meshwork stem cells20 Aug 2015US 2015/0231180 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Trabecular Meshwork Stem Cells20 Sep 2012US 2012/0237485 A1
- Proliferated cell lines and uses thereof14 Jun 2012US 2012/0148540 A1University of Chile
Most cited
By later US patents
- Proliferated cell lines and uses thereof21US 8,137,662 B2University of Chile · 2012
- Conditioned medium and proliferated cell lines produced therefrom12US 8,337,829 B2University of Chile · 2012
- Proliferated cell lines and uses thereof11US 7,416,885 B2University of Chile · 2008
- Trabecular meshwork stem cells1US 10,004,766 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2018